RUNX1T1 and leukemia: Notably, most of the perturbation studies applied fusion gene-specific siRNAs for downmodulation of RUNX1/ETO suggesting that interfering with its expression will ultimately impair leukaemia propagation and hence provides a therapeutic potential.